2009 releases

Display # 
# Article Title Date
1 Vernalis announces clinical update on partnered compounds AUY922 and HSP990 Monday, 14 December 2009
2 Vernalis Earns Milestone Payment in connection with its 2008 sale of Apokyn and its US commercial operations Friday, 11 December 2009
3 Interim Management Statement for the period to 12 November 2009 Thursday, 12 November 2009
4 Vernalis initiates Pilot Study of V3381 in patients with chronic cough Tuesday, 06 October 2009
5 Vernalis completes recruitment in V3381 Phase II IN-STEP study for neuropathic pain Tuesday, 15 September 2009
6 Vernalis and GlaxoSmithKline enter into a collaboration, option and license agreement over a novel Vernalis oncology programme Thursday, 06 August 2009
7 Announcement of Interim results for the six months ended 30 June 2009 Thursday, 06 August 2009
8 Vernalis Announces New Oncology Development Candidate Tuesday, 21 July 2009
9 Vernalis receives milestone payment in Hsp90 inhibitor collaboration Thursday, 16 July 2009
10 Notice of 2009 Half Year Results Wednesday, 08 July 2009

Page 1 of 2

Latest News

Wednesday, 02 May 2012

Successful Outcome for V81444 in Phase I Study

Vernalis today announces the successful outcome of its Phase I trial of V81444